Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENER: Carotid Ultrasound Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Diseases
NCT07611747Phase 4Recruiting
- Sponsor
- IDIVAL
- Start
- Apr 2026
- Primary completion
- Apr 2031
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cardiovascular disease (CVD) and atherosclerosis (2 arms), sponsored by IDIVAL. Primary endpoint: Incidence of Major Adverse Cardiovascular Events at 48 months. Started Apr 2026; status: recruiting.
02
Conditions
cardiovascular disease (CVD)atherosclerosis
Beyond the preview
Go deeper on NCT07611747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07611747.